Brought to you by 
Microbot acquires guidewire IP from Israeli device company CardioSert
24 Jan 2018
Executive Summary
Microbot Medical Inc. acquired CardioSert Ltd.'s technology (including R&D information, technical know-how, and intellectual property) related to guidewires used in cardiovascular applications. The IP includes an issued US patent and three pending patent applications. CardioSert will provide Microbot with three working prototypes of a guidewire incorporating the invention.
Deal Industry
- Medical Devices
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- Includes Royalty or Profit Split Information
- Product Purchase
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Microbot acquires guidewire IP from Israeli device company CardioSert
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice